We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Positron Emission Mammography Technology Used for Novel Radiotracer Research

By MedImaging International staff writers
Posted on 25 Mar 2010
Print article
Universities in the United States are utilizing positron emission mammography (PEM) scanner technology in preclinical and translational research for the development of novel radiotracers.

Johns Hopkins Medicine (Baltimore, MD, USA) has become the latest academic medical center to acquire the Naviscan (San Diego, CA, USA) PEM scanner. The device will be utilized by Richard Wahl, M.D., F.A.C.R, professor of radiology and nuclear medicine at the Johns Hopkins University School of Medicine, in the radiotracer research.

"As the use of Naviscan's organ-specific PET [positron emission tomography] imaging technology continues to be used in cutting-edge breast cancer research and clinical patient management, Naviscan is also developing its use in new clinical applications. As a result, the development and clinical validation of novel radiotracers is essential,” said Paul J. Mirabella, chairman and CEO, Naviscan, Inc.

Dr. Wahl patented the technology that enabled Naviscan to develop the first and only U.S. Food and Drug Administration (FDA)-cleared PET-guided biopsy accessory, known as Stereo Navigator. Naviscan obtained an exclusive license to this patent, which Dr. Wahl developed while he was at the University of Michigan (Ann Arbor, USA).

Other academic medical centers utilizing Naviscan's PEM technology include University of Cincinnati, Baylor University (Waco, TX, USA), M.D. Anderson (Houston, TX, USA), University of Chicago (IL, USA), and the Boston University Medical Center (MA, USA).

Naviscan, Inc. develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiologic and surgical procedures. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the United States and other parts of the world. The company is the first to obtain FDA clearance for a high-resolution PET scanner designed to image small body parts and for breast-biopsy image guidance.

Related Links:

Johns Hopkins Medicine Center
Naviscan


Portable Color Doppler Ultrasound System
S5000
Multi-Use Ultrasound Table
Clinton
Digital X-Ray Detector Panel
Acuity G4
NMUS & MSK Ultrasound
InVisus Pro

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.